Home/Filings/4/0001493152-21-009385
4//SEC Filing

Chapman Christopher C JR 4

Accession 0001493152-21-009385

CIK 0001321834other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 4:53 PM ET

Size

14.5 KB

Accession

0001493152-21-009385

Insider Transaction Report

Form 4
Period: 2021-04-16
Chapman Christopher C JR
DirectorPresident, Chief Med. Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-04-16+77,18077,180 total
    Exercise: $2.59Exp: 2023-04-16Common Stock (77,180 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-04-16+77,18077,180 total
    Exercise: $2.59Exp: 2023-04-16Common Stock (77,180 underlying)
  • Award

    Common Stock

    2021-04-16+96,47596,475 total
  • Award

    Stock Option (Right to Buy)

    2021-04-16+96,47596,475 total
    Exercise: $2.59Exp: 2023-04-16Common Stock (96,475 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-04-16+38,59038,590 total
    Exercise: $2.59Exp: 2023-04-16Common Stock (38,590 underlying)
Footnotes (6)
  • [F1]Received in exchange for 250,000 shares of common stock of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") in connection with the merger of the Former Entity with and into a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share.
  • [F2]Received in the Merger in exchange for a stock option to acquire 100,000 shares of common stock of the Former Entity at $1.00 per share.
  • [F3]These options are fully vested and exercisable.
  • [F4]Received in the Merger in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share.
  • [F5]Received in the Merger in exchange for a stock option to acquire 200,000 shares of common stock of the Former Entity at $1.00 per share.
  • [F6]Received in the Merger in exchange for a stock option to acquire 250,000 shares of common stock of the Former Entity at $1.00 per share.

Documents

1 file

Issuer

MyMD Pharmaceuticals, Inc.

CIK 0001321834

Entity typeother

Related Parties

1
  • filerCIK 0001340428

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:53 PM ET
Size
14.5 KB